TILRAY BRANDS INC (TLRY) Fundamental Analysis & Valuation

NASDAQ:TLRY • US88688T2096

7.35 USD
+0.14 (+1.94%)
At close: Mar 9, 2026
7.27 USD
-0.08 (-1.09%)
After Hours: 3/9/2026, 8:00:01 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This TLRY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

Overall TLRY gets a fundamental rating of 2 out of 10. We evaluated TLRY against 193 industry peers in the Pharmaceuticals industry. TLRY may be in some trouble as it scores bad on both profitability and health. TLRY is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. TLRY Profitability Analysis

1.1 Basic Checks

  • TLRY had negative earnings in the past year.
  • TLRY had a negative operating cash flow in the past year.
  • In the past 5 years TLRY always reported negative net income.
  • TLRY had negative operating cash flow in 4 of the past 5 years.
TLRY Yearly Net Income VS EBIT VS OCF VS FCFTLRY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500M -1B -1.5B -2B

1.2 Ratios

  • TLRY has a Return On Assets of -100.42%. This is in the lower half of the industry: TLRY underperforms 76.17% of its industry peers.
  • With a Return On Equity value of -133.40%, TLRY is not doing good in the industry: 67.36% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -100.42%
ROE -133.4%
ROIC N/A
ROA(3y)-48.32%
ROA(5y)-36.47%
ROE(3y)-65.2%
ROE(5y)-55.79%
ROIC(3y)N/A
ROIC(5y)N/A
TLRY Yearly ROA, ROE, ROICTLRY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100 -200 -300

1.3 Margins

  • With a Gross Margin value of 28.02%, TLRY perfoms like the industry average, outperforming 56.99% of the companies in the same industry.
  • TLRY's Gross Margin has improved in the last couple of years.
  • TLRY does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 28.02%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.36%
GM growth 5YN/A
TLRY Yearly Profit, Operating, Gross MarginsTLRY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. TLRY Health Analysis

2.1 Basic Checks

  • TLRY does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • TLRY has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, TLRY has more shares outstanding
  • TLRY has a worse debt/assets ratio than last year.
TLRY Yearly Shares OutstandingTLRY Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
TLRY Yearly Total Debt VS Total AssetsTLRY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.2 Solvency

  • Based on the Altman-Z score of -1.72, we must say that TLRY is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of TLRY (-1.72) is comparable to the rest of the industry.
  • TLRY has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
  • TLRY has a Debt to Equity ratio (0.18) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Altman-Z -1.72
ROIC/WACCN/A
WACC8.47%
TLRY Yearly LT Debt VS Equity VS FCFTLRY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B

2.3 Liquidity

  • TLRY has a Current Ratio of 2.81. This indicates that TLRY is financially healthy and has no problem in meeting its short term obligations.
  • TLRY's Current ratio of 2.81 is in line compared to the rest of the industry. TLRY outperforms 48.70% of its industry peers.
  • A Quick Ratio of 1.72 indicates that TLRY should not have too much problems paying its short term obligations.
  • The Quick ratio of TLRY (1.72) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.81
Quick Ratio 1.72
TLRY Yearly Current Assets VS Current LiabilitesTLRY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. TLRY Growth Analysis

3.1 Past

  • The earnings per share for TLRY have decreased strongly by -379.00% in the last year.
  • TLRY shows a small growth in Revenue. In the last year, the Revenue has grown by 0.98%.
  • The Revenue has been growing by 37.52% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-379%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%59%
Revenue 1Y (TTM)0.98%
Revenue growth 3Y9.34%
Revenue growth 5Y37.52%
Sales Q2Q%3.11%

3.2 Future

  • The Earnings Per Share is expected to grow by 15.42% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 4.15% on average over the next years.
EPS Next Y96.56%
EPS Next 2Y40.59%
EPS Next 3Y25.77%
EPS Next 5Y15.42%
Revenue Next Year3.75%
Revenue Next 2Y4.25%
Revenue Next 3Y4.03%
Revenue Next 5Y4.15%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
TLRY Yearly Revenue VS EstimatesTLRY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M 1B
TLRY Yearly EPS VS EstimatesTLRY Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -5 -10 -15 -20

More info and screens

Find the best growth stocksShow best growing peers

1

4. TLRY Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for TLRY. In the last year negative earnings were reported.
  • Also next year TLRY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TLRY Price Earnings VS Forward Price EarningsTLRY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

  • 80.83% of the companies in the same industry are more expensive than TLRY, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 20.17
TLRY Per share dataTLRY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10

4.3 Compensation for Growth

  • A more expensive valuation may be justified as TLRY's earnings are expected to grow with 25.77% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.59%
EPS Next 3Y25.77%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. TLRY Dividend Analysis

5.1 Amount

  • TLRY does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TLRY Fundamentals: All Metrics, Ratios and Statistics

TILRAY BRANDS INC

NASDAQ:TLRY (3/9/2026, 8:00:01 PM)

After market: 7.27 -0.08 (-1.09%)

7.35

+0.14 (+1.94%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)01-08
Earnings (Next)04-06
Inst Owners10.43%
Inst Owner Change-88.51%
Ins Owners0.36%
Ins Owner Change0.02%
Market Cap856.35M
Revenue(TTM)837.32M
Net Income(TTM)-2.11B
Analysts70.59
Price Target12.64 (71.97%)
Short Float %12.85%
Short Ratio2.16
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.49%
Min EPS beat(2)-100.98%
Max EPS beat(2)100%
EPS beat(4)1
Avg EPS beat(4)-1374.81%
Min EPS beat(4)-5362.97%
Max EPS beat(4)100%
EPS beat(8)1
Avg EPS beat(8)-733.35%
EPS beat(12)2
Avg EPS beat(12)-748.47%
EPS beat(16)3
Avg EPS beat(16)-621.09%
Revenue beat(2)2
Avg Revenue beat(2)0.75%
Min Revenue beat(2)0.41%
Max Revenue beat(2)1.09%
Revenue beat(4)2
Avg Revenue beat(4)-4.75%
Min Revenue beat(4)-13.28%
Max Revenue beat(4)1.09%
Revenue beat(8)2
Avg Revenue beat(8)-5.24%
Revenue beat(12)3
Avg Revenue beat(12)-2.69%
Revenue beat(16)3
Avg Revenue beat(16)-3.19%
PT rev (1m)0%
PT rev (3m)-26.52%
EPS NQ rev (1m)0%
EPS NQ rev (3m)6.67%
EPS NY rev (1m)0%
EPS NY rev (3m)-936.66%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.07%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.1%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.02
P/FCF N/A
P/OCF N/A
P/B 0.54
P/tB 1.06
EV/EBITDA 20.17
EPS(TTM)-14.37
EYN/A
EPS(NY)-0.36
Fwd EYN/A
FCF(TTM)-0.59
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS7.19
BVpS13.56
TBVpS6.91
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -100.42%
ROE -133.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 28.02%
FCFM N/A
ROA(3y)-48.32%
ROA(5y)-36.47%
ROE(3y)-65.2%
ROE(5y)-55.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.36%
GM growth 5YN/A
F-Score3
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Debt/EBITDA 7.07
Cap/Depr 40.31%
Cap/Sales 4.77%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.81
Quick Ratio 1.72
Altman-Z -1.72
F-Score3
WACC8.47%
ROIC/WACCN/A
Cap/Depr(3y)21.23%
Cap/Depr(5y)65.01%
Cap/Sales(3y)3.68%
Cap/Sales(5y)7.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-379%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%59%
EPS Next Y96.56%
EPS Next 2Y40.59%
EPS Next 3Y25.77%
EPS Next 5Y15.42%
Revenue 1Y (TTM)0.98%
Revenue growth 3Y9.34%
Revenue growth 5Y37.52%
Sales Q2Q%3.11%
Revenue Next Year3.75%
Revenue Next 2Y4.25%
Revenue Next 3Y4.03%
Revenue Next 5Y4.15%
EBIT growth 1Y41.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year109.37%
EBIT Next 3Y28.5%
EBIT Next 5Y17.22%
FCF growth 1Y-53.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-33.64%
OCF growth 3YN/A
OCF growth 5YN/A

TILRAY BRANDS INC / TLRY FAQ

Can you provide the ChartMill fundamental rating for TILRAY BRANDS INC?

ChartMill assigns a fundamental rating of 2 / 10 to TLRY.


What is the valuation status for TLRY stock?

ChartMill assigns a valuation rating of 1 / 10 to TILRAY BRANDS INC (TLRY). This can be considered as Overvalued.


How profitable is TILRAY BRANDS INC (TLRY) stock?

TILRAY BRANDS INC (TLRY) has a profitability rating of 1 / 10.